Pages that link to "Q35913104"
Jump to navigation
Jump to search
The following pages link to Interindividual variability in hepatic expression of the multidrug resistance-associated protein 2 (MRP2/ABCC2): quantification by liquid chromatography/tandem mass spectrometry (Q35913104):
Displaying 38 items.
- Cytochrome P450-dependent catabolism of vitamin K: ω-hydroxylation catalyzed by human CYP4F2 and CYP4F11 (Q24338572) (← links)
- Development of Human Membrane Transporters: Drug Disposition and Pharmacogenetics (Q26786582) (← links)
- Optimized approaches for quantification of drug transporters in tissues and cells by MRM proteomics (Q26851693) (← links)
- The role of transporters in toxicity and disease (Q26999452) (← links)
- Polymorphism of ORM1 is associated with the pharmacokinetics of telmisartan (Q28535089) (← links)
- Role of (drug) transporters in imaging in health and disease (Q30854787) (← links)
- Polymorphisms in genes encoding potential mercury transporters and urine mercury concentrations in populations exposed to mercury vapor from gold mining (Q34439394) (← links)
- The role of quantitative ADME proteomics to support construction of physiologically based pharmacokinetic models for use in small molecule drug development (Q35560052) (← links)
- Human Ontogeny of Drug Transporters: Review and Recommendations of the Pediatric Transporter Working Group (Q35667919) (← links)
- Pharmacogenomics of Methotrexate Membrane Transport Pathway: Can Clinical Response to Methotrexate in Rheumatoid Arthritis Be Predicted? (Q35814091) (← links)
- Mass spectrometry-based targeted proteomics as a tool to elucidate the expression and function of intestinal drug transporters (Q37207759) (← links)
- Stable isotope dilution mass spectrometry for membrane transporter quantitation (Q37207793) (← links)
- Abundance of Hepatic Transporters in Caucasians: A Meta-Analysis (Q37279044) (← links)
- Interindividual variability in hepatic organic anion-transporting polypeptides and P-glycoprotein (ABCB1) protein expression: quantification by liquid chromatography tandem mass spectroscopy and influence of genotype, age, and sex (Q37422685) (← links)
- Comparison of Heavy Labeled (SIL) Peptide versus SILAC Protein Internal Standards for LC-MS/MS Quantification of Hepatic Drug Transporters (Q37639815) (← links)
- The Promises of Quantitative Proteomics in Precision Medicine (Q37647264) (← links)
- Physiologically based pharmacokinetics joined with in vitro-in vivo extrapolation of ADME: a marriage under the arch of systems pharmacology (Q38014312) (← links)
- Absolute abundance and function of intestinal drug transporters: a prerequisite for fully mechanistic in vitro-in vivo extrapolation of oral drug absorption (Q38038547) (← links)
- Species differences in drug transporters and implications for translating preclinical findings to humans (Q38068912) (← links)
- Prediction of pharmacokinetics and drug-drug interactions when hepatic transporters are involved (Q38233298) (← links)
- Genetic polymorphisms in low-dose methotrexate transporters: current relevance as methotrexate therapeutic outcome biomarkers (Q38262203) (← links)
- Three decades of low-dose methotrexate in rheumatoid arthritis: can we predict toxicity? (Q38267703) (← links)
- Translational value of liquid chromatography coupled with tandem mass spectrometry-based quantitative proteomics for in vitro-in vivo extrapolation of drug metabolism and transport and considerations in selecting appropriate techniques (Q38537236) (← links)
- Ontogeny of Hepatic Drug Transporters and Relevance to Drugs Used in Pediatrics (Q38682009) (← links)
- In Vitro Transport Activity and Trafficking of MRP2/ABCC2 Polymorphic Variants. (Q38838936) (← links)
- Causes and Consequences of Variability in Drug Transporter Activity in Pediatric Drug Therapy (Q38888350) (← links)
- Impact of Transporter Polymorphisms on Drug Development: Is It Clinically Significant? (Q38888369) (← links)
- Abundance of Drug Transporters in the Human Kidney Cortex as Quantified by Quantitative Targeted Proteomics (Q39398250) (← links)
- Ontogeny of Hepatic Drug Transporters as Quantified by LC-MS/MS Proteomics (Q39683666) (← links)
- Strategies of Drug Transporter Quantitation by LC-MS: Importance of Peptide Selection and Digestion Efficiency (Q46145015) (← links)
- Role of enterohepatic recirculation in drug disposition: cooperation and complications (Q46578287) (← links)
- Transporter expression in non-cancerous and cancerous liver tissue from donors with hepatocellular carcinoma and chronic hepatitis C infection quantified by LC-MS/MS proteomics. (Q47402203) (← links)
- Critical Issues and Optimized Practices in Quantification of Protein Abundance Level to Determine Interindividual Variability in DMET Proteins by LC-MS/MS Proteomics (Q47917027) (← links)
- Proteomic Analysis of the Developmental Trajectory of Human Hepatic Membrane Transporter Proteins in the First Three Months of Life (Q50518550) (← links)
- Membrane Transporters in Human Parotid Gland-Targeted Proteomics Approach (Q90381515) (← links)
- Are Standard Doses of Renally-Excreted Antiretrovirals in Older Patients Appropriate: A PBPK Study Comparing Exposures in the Elderly Population With Those in Renal Impairment (Q90645326) (← links)
- Interindividual and Regional Variability in Drug Transporter Abundance at the Human Blood-Brain Barrier Measured by Quantitative Targeted Proteomics (Q91179158) (← links)
- Protein Abundance of Clinically Relevant Drug Transporters in the Human Liver and Intestine: A Comparative Analysis in Paired Tissue Specimens (Q93186126) (← links)